{"id":"https://openalex.org/W2073772038","doi":"https://doi.org/10.1038/clpt.2011.319","title":"Safety Learning From Drugs of the Same Class: Room for Improvement","display_name":"Safety Learning From Drugs of the Same Class: Room for Improvement","publication_year":2012,"publication_date":"2012-03-28","ids":{"openalex":"https://openalex.org/W2073772038","doi":"https://doi.org/10.1038/clpt.2011.319","mag":"2073772038","pmid":"https://pubmed.ncbi.nlm.nih.gov/22453192"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.2011.319","doi":"https://doi.org/10.1038/clpt.2011.319","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2011.319","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"G Stefansdottir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"G Stefansdottir","raw_affiliation_strings":["Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands","Division of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091853424","display_name":"Mirjam J. Knol","orcid":"https://orcid.org/0000-0003-0645-5754","observed_orcids":["https://orcid.org/0000-0003-0645-5754"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M J Knol","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands","Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063611476","display_name":"Arna H. Arnardottir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A H Arnardottir","raw_affiliation_strings":["Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044693996","display_name":"Menno E. van der Elst","orcid":"https://orcid.org/0009-0005-6151-6419","observed_orcids":["https://orcid.org/0009-0005-6151-6419"]},"institutions":[{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M E van der Elst","raw_affiliation_strings":["Medicines Evaluation Board, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Evaluation Board, The Hague, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007679161","display_name":"Diederick E. Grobbee","orcid":"https://orcid.org/0000-0003-4472-4468","observed_orcids":["https://orcid.org/0000-0003-4472-4468"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D E Grobbee","raw_affiliation_strings":["Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035747289","display_name":"Hubert G. M. Leufkens","orcid":"https://orcid.org/0000-0002-7175-1499","observed_orcids":["https://orcid.org/0000-0002-7175-1499"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H G M Leufkens","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands","Medicines Evaluation Board, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Medicines Evaluation Board, The Hague, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054001832","display_name":"Marie L. De Bruin","orcid":"https://orcid.org/0000-0001-9197-7068","observed_orcids":["https://orcid.org/0000-0001-9197-7068"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"M L De Bruin","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands","Medicines Evaluation Board, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Medicines Evaluation Board, The Hague, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5054001832"],"corresponding_institution_ids":["https://openalex.org/I193662353","https://openalex.org/I4210150351"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":1.5238,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.81647412,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"91","issue":"5","first_page":"872","last_page":"880"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/safety-learning","display_name":"safety learning","score":0.8080000281333923},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-class-comparison","display_name":"drug class comparison","score":0.5669999718666077},{"id":"https://openalex.org/keywords/summary-of-product-characteristics","display_name":"Summary of Product Characteristics","score":0.9750000238418579},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.8259999752044678},{"id":"https://openalex.org/keywords/proactive-risk-management","display_name":"proactive risk management","score":0.75},{"id":"https://openalex.org/keywords/drug-safety-information","display_name":"drug safety information","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.7209027409553528},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.6917363405227661},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6873494982719421},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.645615816116333},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5693361759185791},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.5191861391067505},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.4979274272918701},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.48728716373443604},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.48157835006713867},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44056493043899536},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.36465051770210266},{"id":"https://openalex.org/C105639569","wikidata":"https://www.wikidata.org/wiki/Q582577","display_name":"Economic policy","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1038/clpt.2011.319","doi":"https://doi.org/10.1038/clpt.2011.319","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2011.319","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:22453192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22453192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/3d21b02b-29b6-455c-8abb-e1f48a8952f6","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/3d21b02b-29b6-455c-8abb-e1f48a8952f6","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Stefansdottir, G, Knol, M J, Arnardottir, A H, van der Elst, M E, Grobbee, D E, Leufkens, H G M & De Bruin, M L 2012, 'Safety Learning From Drugs of the Same Class : Room for Improvement', Clinical Pharmacology & Therapeutics, vol. 91, no. 5, pp. 872-880. https://doi.org/10.1038/clpt.2011.319","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/3d21b02b-29b6-455c-8abb-e1f48a8952f6","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/3d21b02b-29b6-455c-8abb-e1f48a8952f6","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Pharmacology & Therapeutics, 91(5), 872 - 880. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322706","display_name":"Top Institute Pharma","ror":"https://ror.org/01qmxzb47"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W72089021","https://openalex.org/W118048514","https://openalex.org/W1510503817","https://openalex.org/W1969879564","https://openalex.org/W1986016424","https://openalex.org/W1993574752","https://openalex.org/W1995836060","https://openalex.org/W2007929885","https://openalex.org/W2014738583","https://openalex.org/W2017200913","https://openalex.org/W2036132972","https://openalex.org/W2047255362","https://openalex.org/W2073898453","https://openalex.org/W2091843765","https://openalex.org/W2098418526","https://openalex.org/W2126550276","https://openalex.org/W2133491755","https://openalex.org/W2145137957","https://openalex.org/W2147890019","https://openalex.org/W2157584018","https://openalex.org/W4243217122"],"related_works":["https://openalex.org/W1531615023","https://openalex.org/W3112051220","https://openalex.org/W2996690001","https://openalex.org/W6986802524","https://openalex.org/W2071156564","https://openalex.org/W7095744695","https://openalex.org/W2015724156","https://openalex.org/W2588138656","https://openalex.org/W2885739590","https://openalex.org/W2082810976"],"abstract_inverted_index":{"This":[0],"study":[1],"was":[2,146],"aimed":[3],"at":[4],"assessing":[5],"the":[6,18,27,36,54,59,66,73,92,118,121,128,136,143,154,165,168],"extent":[7],"of":[8,17,53,61,65,84,94,97,109,133,138,175,184],"safety":[9,185],"learning":[10,186],"from":[11,39,80,187],"data":[12],"pertaining":[13],"to":[14,41,180],"other":[15,67],"drugs":[16,31,55,96,141],"same":[19,155],"class.":[20],"We":[21,43,76],"studied":[22],"drug":[23,47,82,111,119],"classes":[24],"for":[25,194],"which":[26,85],"first":[28],"and":[29,123,171],"second":[30],"were":[32,89,104,115],"centrally":[33],"registered":[34],"in":[35,58,91,106,127,135,142,153],"European":[37],"Union":[38],"1995":[40],"2008.":[42],"assessed":[44],"whether":[45],"adverse":[46],"reactions":[48],"(ADRs)":[49],"associated":[50,147],"with":[51,148],"one":[52],"also":[56],"appeared":[57,126],"Summary":[60],"Product":[62],"Characteristics":[63],"(SPC)":[64],"drug,":[68],"either":[69],"initially":[70],"or":[71],"during":[72],"postmarketing":[74,129,144],"phase.":[75,130],"identified":[77],"977":[78],"ADRs":[79,87,134],"19":[81],"pairs,":[83],"393":[86,102],"(40.2%)":[88],"listed":[90],"SPCs":[93,108,137],"both":[95,107,139],"a":[98,110,158],"pair.":[99],"Of":[100],"these":[101],"that":[103],"present":[105,116],"pair,":[112],"241":[113],"(61.3%)":[114],"when":[117],"entered":[120],"market":[122,166],"152":[124],"(30.7%)":[125],"The":[131],"mention":[132],"same-class":[140,188],"phase":[145],"type":[149],"A":[150],"ADRs,":[151],"marketing":[152],"regulator":[156],"country,":[157],"longer":[159],"time":[160],"interval":[161],"between":[162],"entry":[163],"into":[164],"by":[167,197],"two":[169],"drugs,":[170,189],"an":[172],"earlier":[173],"date":[174],"ADR.":[176],"Although":[177],"there":[178,190],"appears":[179],"be":[181],"some":[182],"degree":[183],"is":[191],"still":[192],"room":[193],"improvement,":[195],"possibly":[196],"increasing":[198],"proactive":[199],"risk":[200],"management.":[201]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}